logo
  

Why Ocugen Is Rising In Pre-market?

Ocugen, Inc. (OCGN) said its partner, Bharat Biotech, posted positive results from a phase 2 analysis of the vaccine candidate, COVAXIN, in participants ages 12-64, receiving a booster dose six months following a second dose on the pre-print server, medRxiv. The analysis showed that participants receiving a booster dose saw a significant increase in neutralizing titers. Additional data found that more than 75 percent of all participants had a detectible neutralizing antibody response six months post their second dose of COVAXIN. The booster dose analysis also found no serious adverse events, the company noted.

COVAXIN is an investigational vaccine candidate product in the U.S. It was developed by Bharat Biotech in collaboration with the Indian Council of Medical Research - National Institute of Virology.

Shares of Ocugen were up 6% in pre-market trade on Monday.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Ryanair Holdings Plc reported Monday a loss in its fiscal year 2022, narrower than last year, with strong growth in traffic and load factor. Looking ahead, the company said it expects to return to reasonable profitability in fiscal 2023. Shares of the low fares airline were losing around 4 percent in the morning trading in Germany. The U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS has issued a public health alert against Weis Markets' ready-to-eat or RTE General Tso Chicken meals due to misbranding and undeclared milk, a known allergen. The RTE General Tso Chicken meals were prepared, labeled and sold in the Deli area at Weis Markets stores between April 13 and May 11, 2022. Deutsche Telekom AG on Friday raised its fiscal 2022 adjusted earnings forecast after reporting significantly higher net profit in its first quarter. Shares of the German telecom major were gaining around 1 percent in the morning trading in Germany. For fiscal 2022, the company now expects to post adjusted EBITDA AL of more than 36.6 billion euros.
RELATED NEWS
Follow RTT